Moulengui Christ-Emery Kombe, Lekana-Douki Jean-Bernard, Lekana-Douki Sonia Etenna
Unit of Viral Diseases Emergence, Interdisciplinary Center for Medical Research of Franceville (CIRMF), Franceville, Gabon.
Unit of Evolution, Epidemiology and Parasite Resistance, Interdisciplinary Center for Medical Research of Franceville (CIRMF), Franceville, Gabon.
IJID Reg. 2025 Jul 2;16:100699. doi: 10.1016/j.ijregi.2025.100699. eCollection 2025 Sep.
This study aimed to assess the impact of the COVID-19 pandemic on the circulation, prevalence, and diversity of respiratory viruses other than SARS-CoV-2.
Between May 2020 and December 2021, 640 nasopharyngeal swabs were collected from individuals with or without respiratory symptoms, all of whom tested negative for SARS-CoV-2. Samples were analyzed for other respiratory viruses using real-time reverse transcription-polymerase chain reaction.
The overall positivity rate for respiratory viruses was 4.37% (95% confidence interval: 2.79-5.96). Rhinovirus was the most common virus detected (1.25%), followed by PIV4 (0.78%), Human Coronavirus 229E (HCoV-229E) (0.62%), and influenza B (0.46%). Influenza A (H1N1pdm09) and Human Coronavirus OC43 (HCoV-OC43) each had a prevalence of 1%. Other viruses, including H3N2, Human Coronavirus NL63 (HCoV-NL63), and Human Coronavirus HKU1 (HCoV-HKU1), were less frequent (0.15%).
The study reveals a low circulation of respiratory viruses other than SARS-CoV-2 during the period from May 2020 to December 2021. This observation is directly linked to the preponderant circulation of SARS-CoV-2 and the strict measures put in place to limit its transmission.
本研究旨在评估2019冠状病毒病(COVID-19)大流行对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)以外的呼吸道病毒的传播、流行率和多样性的影响。
在2020年5月至2021年12月期间,从有或无呼吸道症状的个体中采集了640份鼻咽拭子,所有个体的SARS-CoV-2检测均为阴性。使用实时逆转录-聚合酶链反应对样本进行其他呼吸道病毒分析。
呼吸道病毒的总体阳性率为4.37%(95%置信区间:2.79-5.96)。检测到的最常见病毒是鼻病毒(1.25%),其次是副流感病毒4型(PIV4,0.78%)、人冠状病毒229E(HCoV-229E,0.62%)和乙型流感(0.46%)。甲型流感(H1N1pdm09)和人冠状病毒OC43(HCoV-OC43)的流行率均为1%。其他病毒,包括H3N2、人冠状病毒NL63(HCoV-NL63)和人冠状病毒HKU1(HCoV-HKU1),出现频率较低(0.15%)。
该研究揭示了2020年5月至2021年12月期间,SARS-CoV-2以外的呼吸道病毒传播率较低。这一观察结果与SARS-CoV-2的优势传播以及为限制其传播而采取的严格措施直接相关。